Cargando…
0.045% DAC N-055 a choice for poor Afghan surgical patients?
Autores principales: | Stahl, KW, Darmangar, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239673/ http://dx.doi.org/10.1186/1753-6561-5-S6-P246 |
Ejemplares similares
-
Lupoid cutaneous leishmaniasis in Afghanistan treated with 0.045% DAC N-055
por: Stahl, KW, et al.
Publicado: (2011) -
A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan
por: Stahl, Hans-Christian, et al.
Publicado: (2014) -
Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults
por: Reddy, Vidhatha, et al.
Publicado: (2020) -
Erbium-doped (Pb(0.9)-Er(0.01)-Zr(0.09)) and (Pb(0.9)-Er(0.01)-Zr(0.045)-Ti(0.045)) nano-crystalline films and nano-rods ceramic synthesis by sol–gel technique for energy-storage application
por: Ibrahim, F. A., et al.
Publicado: (2023) -
Superconductivity with twofold symmetry in Bi(2)Te(3)/FeTe(0.55)Se(0.45) heterostructures
por: Chen, Mingyang, et al.
Publicado: (2018)